Instrumentarium to show Delta16 TACT
Instrumentarium Imaging (Hall B, #8303) has kept a lower profile than some of its mammography competitors regarding the development of digital mammography technology, but that will begin to change at this year's meeting. The Milwaukee company will
Instrumentarium Imaging (Hall B, #8303) has kept a lower profile than some of its mammography competitors regarding the development of digital mammography technology, but that will begin to change at this year's meeting. The Milwaukee company will display Delta16 TACT (tuned-aperture computed tomography), a work-in-progress digital system that may give the company a unique selling point.
Delta16 TACT acquires 2-D digital slices of mammography data acquired from different angles and positions, and reconstructs the data into 3-D images. Tuned aperture refers to the opening through which the breast is viewed, and tuning the aperture's size and shape determines the 3-D picture's degree of completeness.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
